Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
42,795,047
-
Share change
-
+2,528,010
-
Total reported value
-
$3,033,819,410
-
Put/Call ratio
-
160%
-
Price per share
-
$70.90
-
Number of holders
-
232
-
Value change
-
+$177,551,741
-
Number of buys
-
110
-
Number of sells
-
97
Institutional Holders of CANTEL MEDICAL CORP - COM (CMD) as of Q4 2019
As of 31 Dec 2019,
CANTEL MEDICAL CORP - COM (CMD) was held by
232 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
42,795,047 shares.
The largest 10 holders included
BROWN CAPITAL MANAGEMENT LLC, BlackRock Inc., Champlain Investment Partners, LLC, VANGUARD GROUP INC, WASATCH ADVISORS INC, JANUS HENDERSON GROUP PLC, FRED ALGER MANAGEMENT, LLC, Neuberger Berman Group LLC, Conestoga Capital Advisors, LLC, and MACKENZIE FINANCIAL CORP.
This page lists
232
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.